Indication
Abortion
16 clinical trials
15 products
3 drugs
Clinical trial
A Pilot Study of Atorvastatin as a Potential Adjunct to Misoprostol for Termination of PregnancyStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Drug
AtorvastatinProduct
MisoprostolClinical trial
Protocol Title: Reducing Complications and Patient Barriers in Second Trimester Abortion: Pre-Operative Effects of Mifepristone (POEM) on Dilatation and Evacuation ServicesStatus: Completed, Estimated PCD: 2016-06-01
Product
Intra-amniotic DigoxinDrug
MifepristoneClinical trial
Feasibility and Acceptability of Dispensing Mifepristone Via Mail Order PharmacyStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
Use Of Hyoscine as An Adjuvant Treatment on Shortening the Time of Abortion Induction in Second Trimester: Randomized Controlled Clinical TrialStatus: Completed, Estimated PCD: 2023-03-30
Product
BuscopanClinical trial
Gemeprost Versus Dinoprostone in the Medical Management of First Trimester Miscarriages: a Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2025-11-10
Product
GemeprostProduct
DinoprostoneClinical trial
Home-Based Extended Low Dose Buccal Misoprostol Versus Hospital-Based Standard Vaginal Dose In Management Of First Trimester Missed Abortion.Status: Completed, Estimated PCD: 2018-06-01
Clinical trial
Prévention Des Fausses Couches Spontanées Répétées Par Hydroxychloroquine. Essai thérapeutique Multicentrique, randomisé, en Double Insu, Contre PlaceboStatus: Active (not recruiting), Estimated PCD: 2025-11-01
Product
HydroxychloroquineProduct
PlaceboClinical trial
Randomized Controlled Trial of Mifepristone Versus Laminaria for Cervical Ripening In Midtrimester InductionStatus: Completed
Product
mifepristoneClinical trial
Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location: A Randomized Pilot Study of Misoprostol DosingStatus: Recruiting, Estimated PCD: 2024-07-01
Product
MifepristoneProduct
Mifepristone + MisoprostolClinical trial
The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy: a Randomized, Non-inferiority TrialStatus: Recruiting, Estimated PCD: 2024-08-01
Product
LetrozoleClinical trial
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and EvacuationStatus: Completed, Estimated PCD: 2023-07-27
Product
Tranexamic acidDrug
VarlilumabClinical trial
Sequential Use of Foley Catheter With Amniotomy for Second-trimester Pregnancy TerminationStatus: Completed, Estimated PCD: 2023-06-01
Product
OxytocinClinical trial
Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone in First Trimester PregnancyStatus: Recruiting, Estimated PCD: 2025-05-30
Clinical trial
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage Management After Second-trimester Abortion: A Randomized Clinical TrialStatus: Completed, Estimated PCD: 2016-05-31
Clinical trial
Assessing the Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage: a Randomized Controlled TrialStatus: Completed, Estimated PCD: 2020-12-14
Product
lidocaine with vasopressin